1987
DOI: 10.2337/diab.36.11.1341
|View full text |Cite
|
Sign up to set email alerts
|

Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes

Abstract: Increased lipid oxidation is generally observed in subjects with obesity and diabetes and has been suggested to be responsible for the insulin resistance associated with these conditions. We measured, by continuous indirect calorimetry, lipid and glucose oxidation and nonoxidative glucose disposal in 82 obese subjects during a 100-g oral glucose tolerance test (OGTT) and in 26 during a euglycemic insulin (40 mU.min-1.m-2) clamp. The obese subjects were subdivided into those with normal glucose tolerance (group… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
40
0
3

Year Published

1988
1988
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 213 publications
(51 citation statements)
references
References 32 publications
8
40
0
3
Order By: Relevance
“…As demonstrated in this study and by others [35,36], reduced insulin-stimulated glucose uptake in skeletal muscle of obese participants during 12 h of fasting is associated with increased lipid oxidation. This has been proposed in ‘the glucose fatty-acid cycle’ hypothesis by Randle et al in 1963 as the underlying mechanism for reduced insulin-stimulated glucose uptake [37].…”
Section: Discussionsupporting
confidence: 80%
“…As demonstrated in this study and by others [35,36], reduced insulin-stimulated glucose uptake in skeletal muscle of obese participants during 12 h of fasting is associated with increased lipid oxidation. This has been proposed in ‘the glucose fatty-acid cycle’ hypothesis by Randle et al in 1963 as the underlying mechanism for reduced insulin-stimulated glucose uptake [37].…”
Section: Discussionsupporting
confidence: 80%
“…In addition, after an oral fat load, a rather "physiological" condition, postprandial FFAs have been also found higher in diabetics, in accordance with previous studies suggesting elevated circulating FFAs in subjects with obesity, especially abdominal obesity (33)(34), and those with T2DM (35), compared to healthy individuals. Elevated levels of plasma FFAs may have a crucial role in the pathogenesis of T2DM by reducing the utilization of glucose in the peripheral tissues and by increasing the hepatic glucose release, as suggested by Boden G (36).…”
Section: Resultssupporting
confidence: 80%
“…5A). Numerous other metabolic changes are also consistent with obesity, including increased glycogenolysis and glucose availability, decreased glucose oxidation at the Krebs cycle level (Felber et al, 1987), higher glycerol-phosphate generation (Neschen et al, 2005), increased activity of transaminases (elevated aspartate (Hanley et al, 2004)) and accumulation of BCAA, phenylalanine and tryosine (Adams, 2011). …”
Section: Discussionmentioning
confidence: 99%